TGFB1 and B-cell chronic lymphocytic leukemia: Indeed, despite different studies regarding the role of TGF-β/SMAD pathway on CLL clinical progression [28,29], the molecular mechanisms responsible for TGF-β signaling in CLL, as well as the heterogeneity of the functional activity of this pathway among CLL patients with different clinical outcomes, are not completely elucidated yet.